Literature DB >> 19697005

[The value of urinary cytology in the diagnosis of high grade urothelial tumors].

C Niedworok1, V Rembrink, O W Hakenberg, C Börgermann, R Rossi, T Schneider, M Becker, T Szarvas, C von Ostau, A Swoboda, H Rübben, F vom Dorp.   

Abstract

Urinary cytology is a non-invasive adjunct to cystoscopy in the diagnosis of bladder cancer. In order to assess the diagnostic accuracy of urinary cytology as an office-based method for clinically relevant high grade (G3) bladder cancer, three nationwide cytology survey tests were performed. Urine specimens from seven patients, three patients with high grade (G3) bladder cancer and four patients with urinary tract infections, were collected. A total of 1,000 cytology slides were produced from each urine specimen. Each set contained five slides (two malignant, three benign) which were sent to all participating German urologists. Three nationwide tests were performed from 1998-2000. The specimen sets were kept the same for the first and second test and in the third test two new slides were introduced. In addition to validity, the reliability was calculated for the first and second test as interobserver and intraobserver reliability according to Cohen's kappa statistics. Due to the change of two specimens in the third test in 2000 only sensitivity and specificity were calculated. A total of 335 urologists took part in the first survey test, 329 in the second and 292 in the third The sensitivity for G3 cytologies was 81.34% in the first, 87.08% in the second and 85.1% in the third survey test and the specificity was 85.87%, 83.58% and 89.15%, respectively. Interobserver reliability showed a weighted kappa value of 0.58 for the first and 0.59 for the second survey test. Calculation of intraobserver reliability was possible for 169 urologists taking part in the first and second survey test and showed a mean kappa value of 0.62. The results of the three nationwide urinary cytology tests indicate that urinary cytology has a high sensitivity in the detection of clinically relevant high grade bladder cancer. The kappa values achieved demonstrate a clear agreement of cytological diagnoses.

Entities:  

Mesh:

Year:  2009        PMID: 19697005     DOI: 10.1007/s00120-009-2077-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  10 in total

1.  BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder.

Authors:  G Casetta; P Gontero; A Zitella; G Pelucelli; A Formiconi; G Priolo; G Martinasso; G Mengozzi; G Aimo; L Viberti; A Tizzani
Journal:  Urol Int       Date:  2000       Impact factor: 2.089

2.  Improved detection of recurrent bladder cancer using the Bard BTA stat Test.

Authors:  M F Sarosdy; M A Hudson; W J Ellis; M S Soloway; R deVere White; J Sheinfeld; M V Jarowenko; P F Schellhammer; E W Schervish; J V Patel; G W Chodak; D L Lamm; R D Johnson; M Henderson; G Adams; B A Blumenstein; K R Thoelke; R D Pfalzgraf; H A Murchison; S L Brunelle
Journal:  Urology       Date:  1997-09       Impact factor: 2.649

3.  Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?

Authors:  H G Wiener; C Mian; A Haitel; A Pycha; G Schatzl; M Marberger
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

4.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

5.  The accuracy of urinary cytology in daily practice.

Authors:  S Bastacky; S Ibrahim; S P Wilczynski; W M Murphy
Journal:  Cancer       Date:  1999-06-25       Impact factor: 6.860

Review 6.  Urinary markers in the detection of bladder cancer: what's new?

Authors:  Matthew E Nielsen; Edward M Schaeffer; Robert W Veltri; Mark P Schoenberg; Robert H Getzenberg
Journal:  Curr Opin Urol       Date:  2006-09       Impact factor: 2.309

7.  Monitoring patients for bladder neoplasms: what can be expected of urinary cytology consultations in clinical practice.

Authors:  S N Malik; W M Murphy
Journal:  Urology       Date:  1999-07       Impact factor: 2.649

8.  Human complement factor H related protein test for monitoring bladder cancer.

Authors:  M P Raitanen; T Marttila; M Nurmi; M Ala-Opas; P Nieminen; R Aine; T L Tammela
Journal:  J Urol       Date:  2001-02       Impact factor: 7.450

9.  The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.

Authors:  Christine Mian; Michele Lodde; Evi Comploj; Salvatore Palermo; Michael Mian; Klaus Maier; Armin Pycha
Journal:  Anticancer Res       Date:  2005 Sep-Oct       Impact factor: 2.480

10.  Grading of transitional cell tumours of the urinary tract by urinary cytology.

Authors:  H Rübben; J Bubenzer; K Bökenkamp; W Lutzeyer; P Rathert
Journal:  Urol Res       Date:  1979-06-22
  10 in total
  6 in total

Review 1.  [Urine cytology - update 2013. A systematic review of recent literature].

Authors:  M Böhm; F vom Dorp; M Schostak; O W Hakenberg
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

2.  [Exfoliative urine cytology in the treatment of bladder cancer].

Authors:  S Tschirdewahn; F Vom Dorp; H Rübben; O W Hakenberg
Journal:  Urologe A       Date:  2011-03       Impact factor: 0.639

3.  [Urothelial carcinoma of the bladder: evaluation by combined endoscopy and urine cytology: is incontrovertible assessment possible?].

Authors:  J Hess; S Tschirdewahn; T Szarvas; R Rossi; H Rübben; F Vom Dorp
Journal:  Urologe A       Date:  2011-06       Impact factor: 0.639

4.  Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance.

Authors:  Fuming Qi; Yuchen Liu; Rongchang Zhao; Xiangjun Zou; Lei Zhang; Jiaqiang Li; Yongqiang Wang; Feiyang Li; Xiaowen Zou; Ye Xia; Xuliang Wang; Li Xing; Cailing Li; Jingxiao Lu; Junlong Tang; Fangjian Zhou; Chunxiao Liu; Yaoting Gui; Zhiming Cai; Xiaojuan Sun
Journal:  Tumour Biol       Date:  2014-04-27

Review 5.  [Cytology in uropathological diagnostics].

Authors:  N T Gaisa; K Lindemann-Docter
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

6.  Correlation between the cytology of urine sediment in fresh sample and smears stained by Papanicolaou and Giemsa methods.

Authors:  Luis Alberto Palaoro; Margarita Angerosa
Journal:  J Cytol       Date:  2014-01       Impact factor: 1.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.